Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal of Scleroderma and Related Disorders|November 4, 2024
Troponin I levels in systemic sclerosis patients with myocardial involvementEva M Hoekstra, Sophie Ie Liem, Saad Ahmed, et al.Plos One|November 26, 2015
Phenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans CellsCynthia M Fehres, Sven C M Bruijns, Brigit N Sotthewes, et al.European Journal of Immunology|May 15, 2014
Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-primingCynthia M Fehres, Sven C M Bruijns, Astrid J van Beelen, et al.RMD Open|July 28, 2023
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisCorrie M Wortel, Sophie Ie Liem, Nina M van Leeuwen, et al.The Journal of Rheumatology|June 3, 2020
Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic SclerosisNina M van Leeuwen, Corrie M Wortel, Cynthia M Fehres, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 7, 2015
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigensCynthia M Fehres, Hakan Kalay, Sven C M Bruijns, et al.Frontiers in Immunology|July 2, 2019
APRIL Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation via Expression of IL-10 and PD-L1Cynthia M Fehres, Nathalie O van Uden, Nataliya G Yeremenko, et al.Cellular & Molecular Immunology|October 13, 2015
Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cellsCynthia M Fehres, Sanne Duinkerken, Sven Cm Bruijns, et al.RMD Open|February 6, 2023
Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodiesSophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, et al.Arthritis Research & Therapy|July 21, 2023
Anti-carbamylated protein antibodies in systemic sclerosisSophie I E Liem, E M Hoekstra, E W Nivine Levarht, et al.Pageof 3